Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus

• Rudolf K. F. Beran,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Ruchi Sharma,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Amoreena C. Corsa,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Yang Tian,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Justin Golde,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Greta Lundgaard,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• William E. Delaney IV,

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Weidong Zhong,

  Current address: Antiviral Research, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯
• Andrew E. Greenstein

  * E-mail: andrew.greenstein@gilead.com

  Affiliation Biology Department, Gilead Sciences, Foster City, California, United States of America

  ⨯